0      0

350 - Update on Oral and IV Antibiotic Use in Urologic Disease

‐ Nov 3, 2014 1:30pm

A review the current trends in the use of oral and IV is presented. Application to clinical practice is included, with review of indications, adverse affects and prescribing recommendations for advanced practice. A general review of antibiotic resistance is presented.

Contact hours available until 11/3/2016.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Faculty, Planners and Authors Conflict of Interest Disclosure:
Planning Committee Disclosures:

Gina M. Powley, MSN, ANP-BC
Consultant: Ferring Pharmaceuticals, Astellas/Medivation

Leanne Schimke, MSN, CRNP-C, CUNP
Speaker's Bureau: Bayer-Xofigo, Amgen-Denosumab

There are no other disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
Society of Urologic Nurses and Associates is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

SUNA is a provider approved by the California Board of Registered Nursing, provider number, CEP 5556.


• Describe pharmacology of common antibiotics used in urologic disorders.
• Discuss patterns of resistance of antibiotics.
• Choose appropriate therapeutic regimens for challenging urologic infections based on patient characteristics or bacterial resistance.